Chapter 1. GLIOBLASTOMA MULTIFORME TREATMENT (GBM) MARKET- Scope & Methodology
1.1    Market Segmentation
1.2    Assumptions
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. GLIOBLASTOMA MULTIFORME TREATMENT (GBM) MARKET- Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
        2.3.1    Impact during 2023 – 2030
        2.3.2    Impact on Supply – Demand
Chapter 3. GLIOBLASTOMA MULTIFORME TREATMENT (GBM) MARKET- Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. GLIOBLASTOMA MULTIFORME TREATMENT (GBM) MARKET- Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
        4.4.1     Bargaining Power of Suppliers
        4.4.2     Bargaining Powers of Customers
        4.4.3    Threat of New Entrants
        4.4.4     Rivalry among Existing Players
        4.4.5    Threat of Substitutes
Chapter 5. GLIOBLASTOMA MULTIFORME TREATMENT (GBM) MARKET- Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. GLIOBLASTOMA MULTIFORME TREATMENT (GBM) MARKET- By Treatment
6.1    Chemotherapy
6.2    Immunotherapy
6.3    Radiation Therapy
6.4    Surgery
6.5    Targeted Therapy
6.6    Tumor Treating Field (TTF) Therapy
Chapter 7. GLIOBLASTOMA MULTIFORME TREATMENT (GBM) MARKET- By Drug Class
7.1    Bevacizumab
7.2    Carmustine Wafers
7.3    Lomustine
7.4    Temozolomide
7.5    Others
Chapter 8. GLIOBLASTOMA MULTIFORME TREATMENT (GBM) MARKET- By End-Use
8.1    Hospitals
8.2    Clinics
8.3    Ambulatory Surgical Centers
Chapter 9. GLIOBLASTOMA MULTIFORME TREATMENT (GBM) MARKET– By Region
9.1    North America
9.2    Europe
9.3    Asia-Pacific
9.4    Latin America
9.5    The Middle East
9.6    Africa
Chapter 10. GLIOBLASTOMA MULTIFORME TREATMENT (GBM) MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)
10.1    Company 1
10.2    Company 2
10.3    Company 3
10.4    Company 4
10.5    Company 5
10.6    Company 6
10.7    Company 7
10.8    Company 8
10.9    Company 9
10.10    Company 10
 

Download Sample